Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARTIN J BERGMAN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1710977004
CMS profile
305128
Location
RIDLEY PARK, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$47,350.72

137 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARTIN J BERGMAN

NPI 1710977004 · CMS profile ID 305128

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

RIDLEY PARK, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1710977004?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARTIN J BERGMAN, NPI 1710977004, CMS profile ID 305128. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1710977004?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MARTIN J BERGMAN, NPI 1710977004, CMS profile ID 305128. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1710977004?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MARTIN J BERGMAN, NPI 1710977004, CMS profile ID 305128, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1710977004?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

137 matching records · $47,350.72 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 137 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–137 of 137.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $24.9205/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996242493 CMS
AstraZeneca Pharmaceuticals LP $23.7905/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011284809 CMS
PFIZER INC. $27.0805/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050384841 CMS
Amgen Inc. $26.4905/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020016601 CMS
Novartis Pharmaceuticals Corporation $31.2905/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991844317 CMS
Janssen Biotech, Inc. $74.9904/26/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988739625 CMS
Amgen Inc. $28.3104/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020016607 CMS
Janssen Biotech, Inc. $30.1604/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988739627 CMS
GlaxoSmithKline, LLC. $20.6704/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002767895 CMS
AstraZeneca Pharmaceuticals LP $19.6304/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014213217 CMS
PFIZER INC. $9.1804/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130865903 CMS
PFIZER INC. $12.1604/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130865931 CMS
Amgen Inc. $31.4003/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020016599 CMS
Novartis Pharmaceuticals Corporation $26.3503/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991844321 CMS
GlaxoSmithKline, LLC. $12.1203/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002792151 CMS
Amgen Inc. $27.0703/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020016605 CMS
AbbVie Inc. $34.3303/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996242491 CMS
UCB, Inc. $29.1303/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021415021 CMS
E.R. Squibb & Sons, L.L.C. $79.5603/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015881307 CMS
Janssen Biotech, Inc. $9.8302/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988739623 CMS
AbbVie Inc. $33.2202/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996242489 CMS
Janssen Biotech, Inc. $11.4102/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988739629 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.2202/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996611365 CMS
Janssen Biotech, Inc. $3.5702/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988739631 CMS
E.R. Squibb & Sons, L.L.C. $79.5602/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015881303 CMS
GlaxoSmithKline, LLC. $23.1402/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002790269 CMS
Amgen Inc. $29.7001/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020016603 CMS
Novartis Pharmaceuticals Corporation $18.5401/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991844306 CMS
GlaxoSmithKline, LLC. $3,900.0001/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002793929 CMS
Novartis Pharmaceuticals Corporation $20.2101/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991844303 CMS
Kiniksa Pharmaceuticals, Ltd. $20.7801/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058963895 CMS
GlaxoSmithKline, LLC. $10.0301/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002782631 CMS
GlaxoSmithKline, LLC. $112.8601/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002792129 CMS
PFIZER INC. $24.1001/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050305675 CMS
Amgen Inc. $31.0201/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020016597 CMS
E.R. Squibb & Sons, L.L.C. $185.5901/06/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015881285 CMS
E.R. Squibb & Sons, L.L.C. $79.5601/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015881299 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $207,555.89 351
PY2020 $87,565.15 82
PY2021 $59,228.85 99
PY2022 $50,269.34 155
PY2023 $47,350.72 137
PY2024 $6,057.30 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Recipient $3,119.93 3
PY2020 Recipient $8,266.48 13
PY2019 Recipient $4,619.77 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Amgen Inc. $58.62 08/18/2021 Covered Recipient Physician Phase 3 Active Psoriatic Arthritis w/out prior Disease-modifying Antirheumatic Drugs No dispute reported 06/30/2026 830985117
Recipient Novartis Pharmaceuticals Corporation $2,400.00 08/13/2021 Covered Recipient Physician A PHASE III RANDOMIZED DOUBLE BLINDED PLACEBO CONTROLLED MULTICENTER STUDY OF SUBCUTANEOUS SECUKINUMAB 150MG AND 300MG IN PREFILLED SYRINGE TO EMONSTRATE EFFICACY INCLUDING INHIBITION OF STRUCTURAL DAMAGE SAFETY AND TOLERABILITY UP TO 2 YEARS IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS FUTURE 5 No dispute reported 06/30/2026 800637279
Recipient Amgen Inc. $661.31 01/31/2021 Covered Recipient Physician A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group,efficacy and safety study of two doses of apremilast (CC-10004) in subjects with active psoriatic arthritis who have not been treated with disease-modifying antirheu No dispute reported 06/30/2026 830980449